A Multicenter, Prospective, Observational, Non-Interventional Cohort Study Evaluating On-Treatment Predictors of Response in Subjects With HBeAg Positive and HBeAg Negative Chronic Hepatitis B Receiving Therapy With PEGASYS(R) (Peginterferon Alfa-2a 40KD).
Phase of Trial: Phase IV
Latest Information Update: 12 Apr 2017
At a glance
- Drugs Peginterferon alfa-2a (Primary)
- Indications Hepatitis B
- Focus Therapeutic Use
- Acronyms S-Collate
- Sponsors Roche
- 17 Apr 2016 Final 3 years results of this trial (n=1716) presented at The International Liver Congress™ 2016.
- 23 Mar 2015 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov
- 03 Dec 2012 Planned End Date changed from 1 Feb 2016 to 1 Apr 2015 as reported by ClinicalTrials.gov.